Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management - PubMed (original) (raw)

Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management

Anya L Greenberg et al. Int J Equity Health. 2023.

Abstract

Background: Colorectal cancer is a leading cause of morbidity and mortality across U.S. racial/ethnic groups. Existing studies often focus on a particular race/ethnicity or single domain within the care continuum. Granular exploration of disparities among different racial/ethnic groups across the entire colon cancer care continuum is needed. We aimed to characterize differences in colon cancer outcomes by race/ethnicity across each stage of the care continuum.

Methods: We used the 2010-2017 National Cancer Database to examine differences in outcomes by race/ethnicity across six domains: clinical stage at presentation; timing of surgery; access to minimally invasive surgery; post-operative outcomes; utilization of chemotherapy; and cumulative incidence of death. Analysis was via multivariable logistic or median regression, with select demographics, hospital factors, and treatment details as covariates.

Results: 326,003 patients (49.6% female, 24.0% non-White, including 12.7% Black, 6.1% Hispanic/Spanish, 1.3% East Asian, 0.9% Southeast Asian, 0.4% South Asian, 0.3% AIAE, and 0.2% NHOPI) met inclusion criteria. Relative to non-Hispanic White patients: Southeast Asian (OR 1.39, p < 0.01), Hispanic/Spanish (OR 1.11 p < 0.01), and Black (OR 1.09, p < 0.01) patients had increased odds of presenting with advanced clinical stage. Southeast Asian (OR 1.37, p < 0.01), East Asian (OR 1.27, p = 0.05), Hispanic/Spanish (OR 1.05 p = 0.02), and Black (OR 1.05, p < 0.01) patients had increased odds of advanced pathologic stage. Black patients had increased odds of experiencing a surgical delay (OR 1.33, p < 0.01); receiving non-robotic surgery (OR 1.12, p < 0.01); having post-surgical complications (OR 1.29, p < 0.01); initiating chemotherapy more than 90 days post-surgery (OR 1.24, p < 0.01); and omitting chemotherapy altogether (OR 1.12, p = 0.05). Black patients had significantly higher cumulative incidence of death at every pathologic stage relative to non-Hispanic White patients when adjusting for non-modifiable patient factors (p < 0.05, all stages), but these differences were no longer statistically significant when also adjusting for modifiable factors such as insurance status and income.

Conclusions: Non-White patients disproportionately experience advanced stage at presentation. Disparities for Black patients are seen across the entire colon cancer care continuum. Targeted interventions may be appropriate for some groups; however, major system-level transformation is needed to address disparities experienced by Black patients.

Keywords: Colon cancer; Colorectal surgery; Healthcare access; Racial disparities.

© 2023. The Author(s).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1

Fig. 1

Cumulative incidence of death (adjusted for non-modifiable factors), by pathologic stage and Race/Ethnicity

Fig. 2

Fig. 2

Summary of outcomes by Race/Ethnicity

References

    1. Colorectal Cancer Statistics | How Common Is Colorectal Cancer? Accessed April 1, 2023. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html.
    1. Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7(1). Accessed August 15, 2022. https://jgo.amegroups.com/article/view/4685. -PMC -PubMed
    1. Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health. 2010;100(10):1912–1916. doi: 10.2105/AJPH.2009.184192. -DOI -PMC -PubMed
    1. Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(4):401–405. doi: 10.1200/JCO.2011.37.5527. -DOI -PubMed
    1. Myers RE, Stello B, Daskalakis C, et al. Decision support and navigation to increase colorectal cancer screening among hispanic patients. Cancer Epidemiol Biomarkers Prev. 2019;28(2):384–391. doi: 10.1158/1055-9965.EPI-18-0260. -DOI -PubMed

MeSH terms

LinkOut - more resources